APA (7th ed.) Citation

Madan, A., Ferguson, M., Rheault, P., Seiden, D., Toma, A., Friel, D., . . . Schuind, A. (2017). Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65 years of age and older: A phase II, observer-blind, randomized, controlled trial. Vaccine, 35(15), 1865. https://doi.org/10.1016/j.vaccine.2017.02.057

Chicago Style (17th ed.) Citation

Madan, Anuradha, et al. "Immunogenicity and Safety of an AS03-adjuvanted H7N1 Vaccine in Adults 65 Years of Age and Older: A Phase II, Observer-blind, Randomized, Controlled Trial." Vaccine 35, no. 15 (2017): 1865. https://doi.org/10.1016/j.vaccine.2017.02.057.

MLA (9th ed.) Citation

Madan, Anuradha, et al. "Immunogenicity and Safety of an AS03-adjuvanted H7N1 Vaccine in Adults 65 Years of Age and Older: A Phase II, Observer-blind, Randomized, Controlled Trial." Vaccine, vol. 35, no. 15, 2017, p. 1865, https://doi.org/10.1016/j.vaccine.2017.02.057.